ANIK Anika Therapeutics, Inc.

NASDAQ
$20.37

Anika Therapeutics, Inc. (ANIK) is expected to report earnings on November 2, 2026, before the market open. The consensus earnings estimate is $0.02 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +18.2% since its last earnings release on July 29, 2026.

Anika Therapeutics Beat Consensus Estimates, Raises Guidance, but Remains In-line with Estimates
Wednesday, July 29, 2026 · 7:05 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 2
Monday · 7:05 AM ET
Earnings Whisper
-
vs $0.02
Rev est $30.07M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $20.73

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Anika Therapeutics, Inc.

Anika Therapeutics, Inc., is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care.

Sector

Healthcare

Industry

Biotechnology

Held By 2 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.